Skip to content

Drug interactions

Peginterferon alfa 2b + Pegvaliase

Severity: Moderate

Peginterferon alfa 2b and Pegvaliase: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Most pegvaliase-treated patients develop anti-PEG antibodies, which could in theory increase hypersensitivity risk or reduce exposure to other PEGylated products such as peginterferon. The clinical consequence is not established.

What this interaction means in plain words

Peginterferon alfa 2b and Pegvaliase can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Peginterferon alfa 2b belongs to Anti Virals; Pegvaliase belongs to Miscellaneous.

Evidence level: Low

Why it happens

Possible cross-reactivity of anti-PEG antibodies with other PEGylated products.

What to do

Monitor for hypersensitivity reactions after peginterferon doses and for loss of response. Ensure pegvaliase-related anaphylaxis precautions, including auto-injectable epinephrine, remain in place.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Peginterferon alfa 2b and Pegvaliase, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Peginterferon alfa 2b with Pegvaliase?

MediHelp rates the interaction as moderate. Peginterferon alfa 2b and Pegvaliase can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Most pegvaliase-treated patients develop anti-PEG antibodies, which could in theory increase hypersensitivity risk or reduce exposure to other PEGylated products such as peginterferon. The clinical consequence is not established.

How serious is the interaction between Peginterferon alfa 2b and Pegvaliase?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for hypersensitivity reactions after peginterferon doses and for loss of response. Ensure pegvaliase-related anaphylaxis precautions, including auto-injectable epinephrine, remain in place.

What other medicines interact with Peginterferon alfa 2b?

MediHelp also lists interactions of Peginterferon alfa 2b with, for example, Aldesleukin, Deferiprone, Pexidartinib. The full list is on the Peginterferon alfa 2b page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in